| (ILA) | Mar 2016 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, XTLB.TA returned +4778.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +8233.3% |
| 1 year | +4778.0% |
| 5 years | +1182.1% |
| 10 years | +895.0% |
| All-time high | ILA 2.00 (Aug 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what ILA1,000 in XTLB.TA would be worth today ›No. XTL Biopharmaceuticals Ltd. has not paid a dividend in the past 12 months.
XTL Biopharmaceuticals Ltd. is part of the Healthcare sector.
XTL Biopharmaceuticals Ltd. has a market cap of 19.66M ILA, based on the latest quote.
